Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Immunology

Independently Acquired Biallelic JAK2 Mutations Are Present in a Minority of Patients With Essential Thrombocythemia

Blood

English

Leukemic Phase of ALK-positive Anaplastic Large Cell Lymphoma

English

AAML0523: A Report From the Children's Oncology Group on the Efficacy of Clofarabine in Combination With Cytarabine in Pediatric Patients With Relapsed Acute Myeloid Leukemia

English

Patient Preferences for Stopping Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

English

EVI-1 Oncogene Expression Predicts Survival in Chronic-Phase CML Patients Resistant to Imatinib Treated With Second-Generation Tyrosine Kinase Inhibitors

English

Phase 1b Study of Venetoclax-Obinutuzumab in Previously Untreated and Relapsed/Refractory Chronic Lymphocytic Leukemia

English

Reduction of the Six-Minute Walk Distance in Children With Sickle Cell Disease Is Correlated With Silent Infarct: Results From a Cross-Sectional Evaluation in a Single Center in Belgium.

English

Cyclosporine Modulation of Multidrug Resistance in Combination With Pravastatin, Mitoxantrone, and Etoposide for Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML): A Phase 1/2 Study

English

Targeted Therapy of CNS Leukemia?

English

Sirolimus Is Effective in Relapsed/Refractory Autoimmune Cytopenias: Results of a Prospective Multi-Institutional Trial

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Immunology

Independently Acquired Biallelic JAK2 Mutations Are Present in a Minority of Patients With Essential Thrombocythemia

Leukemic Phase of ALK-positive Anaplastic Large Cell Lymphoma

AAML0523: A Report From the Children's Oncology Group on the Efficacy of Clofarabine in Combination With Cytarabine in Pediatric Patients With Relapsed Acute Myeloid Leukemia

Patient Preferences for Stopping Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

EVI-1 Oncogene Expression Predicts Survival in Chronic-Phase CML Patients Resistant to Imatinib Treated With Second-Generation Tyrosine Kinase Inhibitors

Phase 1b Study of Venetoclax-Obinutuzumab in Previously Untreated and Relapsed/Refractory Chronic Lymphocytic Leukemia

Reduction of the Six-Minute Walk Distance in Children With Sickle Cell Disease Is Correlated With Silent Infarct: Results From a Cross-Sectional Evaluation in a Single Center in Belgium.

Cyclosporine Modulation of Multidrug Resistance in Combination With Pravastatin, Mitoxantrone, and Etoposide for Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML): A Phase 1/2 Study

Targeted Therapy of CNS Leukemia?

Sirolimus Is Effective in Relapsed/Refractory Autoimmune Cytopenias: Results of a Prospective Multi-Institutional Trial